Ondansetron HCL 4 MG tablet 500S
Ended Awarded
- Contract number
- SPE2DB26FWGCB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $37,651
Award facts
- Contract value 100% obligated
- $37,651.42 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Ondansetron HCL 4 mg tablets (500 count) valued at $37,651.42. This firm fixed price delivery order, with an ultimate completion date of November 10, 2025, was competitively awarded without a set-aside designation. The award leverages AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to military healthcare systems worldwide. Performance will be executed from the company's corporate office location in Conshohocken, Pennsylvania.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal healthcare vendor that serves military and veteran healthcare systems through an extensive portfolio of federal contract awards with DLA and other government agencies. The company's federal procurement track record demonstrates significant capability in fulfilling diverse medical supply requirements, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This delivery order for Ondansetron HCL, a commonly used antiemetic medication, exemplifies the company's role as a key supplier within the federal medical supply chain supporting defense health operations.
Quick answers
Who was awarded contract SPE2DB26FWGCB?
SPE2DB26FWGCB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 7, 2025.
How much is contract SPE2DB26FWGCB worth?
The government has obligated $37,651 on SPE2DB26FWGCB.
Is contract SPE2DB26FWGCB an order under another contract?
Yes. SPE2DB26FWGCB is a delivery order under SPE2DB25D3020, an indefinite delivery contract.
Was contract SPE2DB26FWGCB competed?
The extent of competition for SPE2DB26FWGCB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award